MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1245/s10434-021-10777-6

Медицинская библиотека · Annals of surgical oncology · 2021

Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors-A Nationwide Experience.

Blanc Thomas, Meignan Pierre, Vinit Nicolas, Ballouhey Quentin, Pio Luca, Capito Carmen, Harte Caroline, Vatta Fabrizio, Galmiche-Rolland Louise, Minard Véronique, Orbach Daniel, Berteloot Laureline, Muller Cécile, Kohaut Jules, Broch Aline, Braik Karim, Binet Aurélien, Heloury Yves, Fourcade Laurent, Lardy Hubert, Sarnacki Sabine

СтатьяПеревод в очереди

Аннотация

BACKGROUND

While robotics has become commonplace in adult oncology, it remains rare in pediatric oncology due to the rarity of childhood cancers. We present the results of a large nationwide experience with robotic oncology, with the aim of providing practical and feasible guidelines for child selection.

METHODS

This was a prospective analysis performed over a period of 4 years. Treatment was delivered according to the Société Internationale d'Oncologie Pédiatrique/International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOP/SIOPEN) protocols. Indications were approved by a certified tumor board.

RESULTS

Overall, 100 tumors were resected during 93 procedures (abdomen, 67%; thorax, 17%; pelvis, 10%; retroperitoneum, 6%) in 89 children (56 girls). The median age at surgery was 8.2 years (range 3.6-13); 19 children (21%) harbored germinal genetic alterations predisposing to cancer. No intraoperative tumor ruptures occurred. Seven conversions (8%) to an open approach were performed. Neuroblastic tumors (n = 31) comprised the main group (18 neuroblastomas, 4 ganglioneuroblastomas, 9 ganglioneuromas) and renal tumors comprised the second largest group (n = 24, including 20 Wilms' tumors). The remaining 45 tumors included neuroendocrine (n = 12), adrenal (n = 9), germ-cell (n = 7), pancreatic (n = 4), thymic (n = 4), inflammatory myofibroblastic (n = 4), and different rare tumors (n = 5). Overall, 51 tumors were malignant, 2 were borderline, and 47 were benign. The median hospital stay was 3 days (2-4), and five postoperative complications occurred within the first 30 days. During a median follow-up of 2.4 years, one child (Wilms' tumor) presented with pleural recurrence. One girl with Wilms' tumor died of central nervous system metastasis.

CONCLUSIONS

Robotic surgery for pediatric tumors is a safe option in highly selected cases. Indications should be discussed by tumor boards to avoid widespread and uncontrolled application.

Для цитирования: Blanc Thomas, Meignan Pierre, Vinit Nicolas, Ballouhey Quentin, Pio Luca, Capito Carmen, Harte Caroline, Vatta Fabrizio, Galmiche-Rolland Louise, Minard Véronique, Orbach Daniel, Berteloot Laureline, Muller Cécile, Kohaut Jules, Broch Aline, Braik Karim, Binet Aurélien, Heloury Yves, Fourcade Laurent, Lardy Hubert, Sarnacki Sabine. Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors-A Nationwide Experience.. Annals of surgical oncology. 2021. DOI: 10.1245/s10434-021-10777-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.